Featured Patient Story: Steve Lucido

Back to Normal after Prostate Cancer Treatment

At age 56, Steve Lucido had a routine blood test, which revealed a high level of prostate-specific antigen (PSA), indicating prostate cancer. After extensive research, Lucido learned that researchers and surgeons at Johns Hopkins were performing prostate cancer surgery with a technique that reduces the risks for incontinence and impotence. After reaching out to Dr. Edward Schaeffer, researcher and surgeon at Johns Hopkins, Lucido underwent a radical prostatectomy in October 2008. Today, Lucido is cancer-free and back to his active life.

Video: Common Ground - Hope for Prostate Cancer at Johns ...

Steve Lucido survived prostate cancer and feels it was due to the expertise of his surgeon Dr. Ted Schaeffer. Learn why Johns Hopkins is at the forefront of prostate treatment and research.

Date: 02/07/2011

About the Johns Hopkins James Buchanan Brady Urological Institute

The Johns Hopkins James Buchanan Brady Urological Institute offers comprehensive treatment options for all urological conditions, including bladder cancer. There are new treatment approaches being developed and the collaborative effort of clinicians and researchers here have led to many advances in the treatment and understanding of the urinary tract and urinary tract cancer.

Learn more about the Johns Hopkins James Buchanan Brady Urological Institute